A Biocon spokesperson said the company is confident of addressing these observations through procedural enhancements and an appropriate Corrective and Preventive Action Plan (CAPA), which will be submitted to the USFDA in the stipulated time.
from International-News-Economic Times https://ift.tt/3AIlFmD
via IFTTT
Home
Global Updates
IFTTT
International-News-Economic Times
Latest News
World News
USFDA issues six observations after inspection of Biocon's Malaysian arm manufacturing facility
- Blogger Comment
- Facebook Comment
Subscribe to:
Post Comments
(
Atom
)
0 comments:
Post a Comment